Posts
- IRISYS, LLC celebrates 24 years of pharmaceutical formulation R&D and manufacturing success
- IRISYS, LLC Keeping Our Staff Safe During COVID-19
- Yakatan Fund at Temple University
- IRISYS, LLC Manufacturing Clinical Trial ACT-1 Ophthalmic Solution For Corneal Healing
- Meeting: Dispelling the Mystique of Pre-IND Meetings
- The Future Of Drug Development in China
- IRISYS receives Exceptional rating as contractor from NCI
- Event: Formulation Development and Excipient Selection
- How New Drugs Are Made
- Event: FDA Regulatory Strategies and CMC Considerations
- Lifetime Achievement Award from “Marquis Who’s Who” Given to Dr. Jerry Yakatan
- Staying Knowledgeable About FDA Changes
- The Team Approach
- A Fight We’re Eager to Engage In
- Outside Focus & Inner Wellness
- Proprietary Liposomal Formulation Platform Technology Partnership Opportunity
- To Maintain Trust In Science, Lose The Peer Review
- China’s Struggle To Shake It’s Reputational Issues in 2019
- Potential Threats That Could Affect Pharma Manufacturing
- The Very Real Risk Of Cheaper Drugs
- China’s CROs Make Connection in S.D.
- Getting Children What They Deserve
- CPhI Points To Increase Growth For China
- The Problem That Is Affecting Chinese American Researchers
- Taking a breather with our new Be Healthy Club
- Video: Automatic Syringe Filling Machine for Gel Dosage Form
- Pharmaceutical Services: The Growing Popularity of Outsourcing
- Build me a house - No power tools needed?!
- Z-Endoxifen manufactured for the National Cancer Institute
- The Yakatan Rules for Pharma R&D Efficiency #2
- The Yakatan Rules for Pharma R&D Efficiency #1
- San Diego Food Bank Initiative – Food 4 Kids Backpack Program
- Poor solubility and rapid degradation in acidic environments
- Are you new to the concept of Current Good Manufacturing Practices (cGMPs)?
Pages
- About Us
- GMP Manufacturing
- Contact Us
- Home
- Formulation Technologies
- Difficult to Develop Products
- Liquid Formulation Development and Manufacturing
- Novel Drug Delivery Technologies
- Analytical Support
- Creams & Ointments Development & Manufacturing
- Sustained Release Dosage Forms
- Topical Formulations
- IRISYS Delivers Phase-Appropriate Formulation Solutions
- Examples of IRISYS Technologies Applied
- Parenteral Formulation Development
- Strategic Consulting
- Newsroom
- Terms and Conditions
- Privacy Policy
- Blog
Press Releases
- IRISYS To Expand Drug Delivery Technology Capabilities & Services in China
- IRISYS Chairman, CEO & Founder Represents Biotech Industry at San Diego US-China Trade Relations Meeting
- IRISYS Chairman, CEO & Founder Recognized as “International Cooperation Ambassador” for Life Science City in China
- Gerald Joseph Yakatan, PhD, Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who’s Who
- BioCorRx Partners with IRISYS for Manufacturing of BICX102 Naltrexone Implant for Treatment of Opioid Use Disorder
- Director of Research and Development featured in Journal of Current Pharmaceutical Biotechnology
- IRISYS’ SCOT-TUSSIN Products will be Exhibited at the 2018 Cardinal Health Retail Business Conference
- IRISYS Awarded NCATS “CRO Support for Drug Product Development, Manufacture, and Stability Studies” Contract for Up To $14.4 Million
- IRISYS Announces Dr. Robert Giannini, Ph.D., As New President
- IRISYS Announces New State of the Art Equipment
- IRISYS Discussions at CPhI China feature Gerald Yakatan, Ph.D., Chairman, CEO & Founder
- IRISYS Awarded NIH “Drug Formulation and Manufacturing” Contract for Up To $45 Million
- IRISYS Management is in High Demand at Contract Manufacturing / Packaging / Logistics for Pharmaceuticals & Nutritionals Conference
- IRISYS Expertise and Asian Outreach Discussed at BIOtech Japan 2017 Conference
- IRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D., is a Featured “Innovative Thought Leader” at the 7th Clinical Trials Innovation Programme
- IRISYS Exhibits at Inaugural CPhI North America Conference
- IRISYS Contract with NCI for Manufacturing Clinical Trial Materials is Doubled in Value
- IRISYS to be Represented at CPhI Japan by Chairman, CEO & Founder Gerald Yakatan, Ph.D.
- IRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D., Participates in the 8th Annual Life Science CEO Forum
- IRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D., Moderates FDA Panel at The International Conference on Drug Development
- IRISYS Awarded Long Term Contract by NCI for Manufacturing Clinical Trial Materials
- IRISYS Receives MetroConnect Award & California Competes Tax Credit